STELARA™ (Ustekinumab) Receives Fda Approval For Treatment Of Moderate To Severe Plaque Psoriasis... (Continue reading)
Provectus Pharmaceuticals Inc. has begun a compassionate use program for PV-10 and has made the agent, which is in development as a therapeutic drug for a broad spectrum of cancers, available for select cancer patients.... (Continue reading)